Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 46, 2011 - Issue 4
Submit an article Journal homepage
546
Views
53
CrossRef citations to date
0
Altmetric
Liver and biliary tract

Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)

Noreen Hossain Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA; Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, USA
,
Maria Stepanova Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA
,
Arian Afendy Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA; Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, USA
,
Fatema Nader Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA; Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, USA
,
Youssef Younossi Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA
,
Nila Rafiq Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA; Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, USA
,
Zachary Goodman Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, USA
&
Zobair M. Younossi Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA; Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, USACorrespondence[email protected]
 show all
Pages 479-484 | Received 29 Dec 2009, Accepted 07 Nov 2010, Published online: 30 Nov 2010

Citations (53)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Dongxu Wang & Bing He. (2022) Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome. Diabetes, Metabolic Syndrome and Obesity 15, pages 1281-1291.
Read now
Kristian Bjøro. (2011) This Month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 46:4, pages 387-388.
Read now

Articles from other publishers (51)

Ioannis G. Lempesis, Samuel J. Apple, Gustavo Duarte, Leonidas Palaiodimos, Dimitrios Rafail Kalaitzopoulos, Maria Dalamaga & Damianos G. Kokkinidis. (2023) Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndrome. Diabetes/Metabolism Research and Reviews 39:6.
Crossref
Sourav Chakraborty, Santosh Anand, Seraiah Coe, Beh Reh & Ramji Kumar Bhandari. (2023) The PCOS–NAFLD Multidisease Phenotype Occurred in Medaka Fish Four Generations after the Removal of Bisphenol A Exposure. Environmental Science & Technology 57:34, pages 12602-12619.
Crossref
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Sandra Kannampuzha, Reshma Murali, Arunraj Namachivayam, Raja Ganesan, Abhijit Dey, Achsha Babu, Kaviyarasi Renu, Balachandar Vellingiri, Gnanasambandan Ramanathan, George Priya Doss C., Nehal Elsherbiny, Amira M. Elsherbini, Alsamman M. Alsamman, Hatem Zayed & Abilash Valsala Gopalakrishnan. (2023) The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review. Metabolites 13:1, pages 129.
Crossref
Abdulrahman Ismaiel, Piero Portincasa & Dan L. Dumitrascu. 2023. Essentials of Non-Alcoholic Fatty Liver Disease. Essentials of Non-Alcoholic Fatty Liver Disease 19 43 .
Sara Arefhosseini, Mehrangiz Ebrahimi-Mameghani, Farzad Najafipour & Helda Tutunchi. (2022) Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones. Frontiers in Endocrinology 13.
Crossref
Amanda Medeiros Recuero, Larissa Garcia Gomes, Gustavo Arantes Rosa Maciel, Fernanda de Mello Malta, Ana Paula Moreira Salles, Denise Cerqueira Paranaguá Vezozzo, Edmund Chada Baracat, João Renato Rebello Pinho, Flair José Carrilho, José Tadeu Stefano & Claudia P. Oliveira. (2022) NAFLD in Polycystic Ovary Syndrome: Association with PNPLA3 and Metabolic Features. Biomedicines 10:11, pages 2719.
Crossref
Łukasz Blukacz, Artur Nowak, Mariusz Wójtowicz, Angelika Krawczyk, Grzegorz Franik, Paweł Madej, Dagmara Pluta, Karolina Kowalczyk & Michał Żorniak. (2022) Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence. Biomedicines 10:9, pages 2193.
Crossref
Tülay OMMA, Fatmanur Hümeyra ZENGİN, Süheyla AYDOĞMUŞ & Cavit ÇULHA. (2022) Metabolic status is not related to dietary acid load in polycystic ovary syndromeMetabolic status is not related to dietary acid load in polycystic ovary syndrome. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi 55:2, pages 111-115.
Crossref
P. Barton Duell, Francine K. Welty, Michael Miller, Alan Chait, Gmerice Hammond, Zahid Ahmad, David E. Cohen, Jay D. Horton, Gregg S. Pressman & Peter P. Toth. (2022) Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 42:6.
Crossref
Iliana Doycheva & David A. Ehrmann. (2022) Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome. Fertility and Sterility 117:5, pages 897-911.
Crossref
Carmen Emanuela Georgescu. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome 187 216 .
Eleni Armeni & Irene Lambrinoudaki. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome 245 285 .
Emily L. Zumbro, Manisha Rao, Shenavia Balcom-Luker, K. Shane Broughton & Monique J. LeMieux. (2021) Whey Protein Supplementation Improves the Glycemic Response and May Reduce Non-Alcoholic Fatty Liver Disease Related Biomarkers in Women with Polycystic Ovary Syndrome (PCOS). Nutrients 13:7, pages 2451.
Crossref
Sebastião Freitas de Medeiros, Raymond Joseph Rodgers & Robert John Norman. (2021) Adipocyte and steroidogenic cell cross-talk in polycystic ovary syndrome. Human Reproduction Update 27:4, pages 771-796.
Crossref
Ana-Maria Singeap, Carol Stanciu, Laura Huiban, Cristina Maria Muzica, Tudor Cuciureanu, Irina Girleanu, Stefan Chiriac, Sebastian Zenovia, Robert Nastasa, Catalin Sfarti, Camelia Cojocariu & Anca Trifan. (2021) Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications. Canadian Journal of Gastroenterology and Hepatology 2021, pages 1-8.
Crossref
Agostino Di Ciaula, Grigorios Christidis, Marcin Krawczyk, Frank Lammert & Piero Portincasa. 2021. Endocrinology and Systemic Diseases. Endocrinology and Systemic Diseases 157 177 .
Soung Won Jeong. (2020) Nonalcoholic Fatty Liver Disease: A Drug Revolution Is Coming. Diabetes & Metabolism Journal 44:5, pages 640-657.
Crossref
Terence T. Lao. (2020) Implications of abnormal liver function in pregnancy and non-alcoholic fatty liver disease. Best Practice & Research Clinical Obstetrics & Gynaecology 68, pages 2-11.
Crossref
Monika Sarkar, Norah Terrault, Wesley Chan, Marcelle I. Cedars, Heather G. Huddleston, Caroline C. Duwaerts, Dana Balitzer & Ryan M. Gill. (2019) Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis. Liver International 40:2, pages 355-359.
Crossref
Giovanni Targher & Alessandro Mantovani. 2020. Non-Alcoholic Fatty Liver Disease. Non-Alcoholic Fatty Liver Disease 147 168 .
Agostino Di Ciaula, Grigorios Christidis, Marcin Krawczyk, Frank Lammert & Piero Portincasa. 2020. Endocrinology and Systemic Diseases. Endocrinology and Systemic Diseases 1 21 .
Anaïs Vallet-Pichard, Lucia Parlati & Stanislas Pol. (2019) Épidémiologie de la stéato-hépatite non alcoolique. Étendue du problème et son impact sur la santé publique. La Presse Médicale 48:12, pages 1459-1467.
Crossref
Gregor Holzer & Beatrix Volc‐Platzer. 2019. Harper's Textbook of Pediatric Dermatology. Harper's Textbook of Pediatric Dermatology 841 858 .
Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari & Giovanni Targher. (2019) NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management. International Journal of Molecular Sciences 20:11, pages 2841.
Crossref
Jariya Buniam, Natsasi Chukijrungroat, Tanaporn Khamphaya, Jittima Weerachayaphorn & Vitoon Saengsirisuwan. (2019) Estrogen and voluntary exercise attenuate cardiometabolic syndrome and hepatic steatosis in ovariectomized rats fed a high-fat high-fructose diet. American Journal of Physiology-Endocrinology and Metabolism 316:5, pages E908-E921.
Crossref
Julie Steen Pedersen & Flemming Bendtsen. 2019. The Human Gut-Liver-Axis in Health and Disease. The Human Gut-Liver-Axis in Health and Disease 23 46 .
Alpana Shukla & Lindsay Mandel. 2019. Obesity Management. Obesity Management 31 40 .
Jia Wu, Xin-Yu Yao, Ru-Xia Shi, Su-Fen Liu & Xiao-Yong Wang. (2018) A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis. Reproductive Health 15:1.
Crossref
Panagiotis Anagnostis, Basil C. Tarlatzis & Robert P. Kauffman. (2018) Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. Metabolism 86, pages 33-43.
Crossref
N S Kakoly, M B Khomami, A E Joham, S D Cooray, M L Misso, R J Norman, C L Harrison, S Ranasinha, H J Teede & L J Moran. (2018) Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Human Reproduction Update 24:4, pages 455-467.
Crossref
Naga Chalasani, Zobair Younossi, Joel E. Lavine, Michael Charlton, Kenneth Cusi, Mary Rinella, Stephen A. Harrison, Elizabeth M. Brunt & Arun J. Sanyal. (2017) The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67:1, pages 328-357.
Crossref
A. L. L. Rocha, L. C. Faria, T. C. M. Guimarães, G. V. Moreira, A. L. Cândido, C. A. Couto & F. M. Reis. (2017) Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. Journal of Endocrinological Investigation 40:12, pages 1279-1288.
Crossref
Djuro Macut, Ivana Božić-Antić, Jelica Bjekić-Macut & Konstantinos Tziomalos. (2017) MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease. European Journal of Endocrinology 177:3, pages R145-R158.
Crossref
Natsasi ChukijrungroatTanaporn Khamphaya, Jittima WeerachayaphornThaweesak Songserm & Vitoon Saengsirisuwan. (2017) Hepatic FGF21 mediates sex differences in high-fat high-fructose diet-induced fatty liver. American Journal of Physiology-Endocrinology and Metabolism 313:2, pages E203-E212.
Crossref
Matea BelanChloé PelletierJean-Patrice Baillargeon. (2017) Alanine Aminotransferase Is a Marker of Lipotoxicity Consequences and Hyperandrogenemia in Women with Polycystic Ovary Syndrome. Metabolic Syndrome and Related Disorders 15:3, pages 145-152.
Crossref
Mei-Jou Chen & Hong-Nerng Ho. (2016) Hepatic manifestations of women with polycystic ovary syndrome. Best Practice & Research Clinical Obstetrics & Gynaecology 37, pages 119-128.
Crossref
Lorena Leal Canosa & Mireia Rojas Torrijos. (2016) Síndrome del ovario poliquístico y piel. Piel 31:7, pages 485-495.
Crossref
Giovanni Targher, Maurizio Rossini & Amedeo Lonardo. (2015) Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?. Endocrine 51:2, pages 211-221.
Crossref
Elizabeth M. Brunt, Vincent W.-S. Wong, Valerio Nobili, Christopher P. Day, Silvia Sookoian, Jacquelyn J. Maher, Elisabetta Bugianesi, Claude B. Sirlin, Brent A. Neuschwander-Tetri & Mary E. Rinella. (2015) Nonalcoholic fatty liver disease. Nature Reviews Disease Primers 1:1.
Crossref
Stergios A. Polyzos, Dimitrios G. Goulis & Jannis Kountouras. (2015) Nonalcoholic fatty liver disease and polycystic ovary syndrome. Annals of Hepatology 14:6, pages 941-943.
Crossref
Laura Marino. (2015) Endocrine causes of nonalcoholic fatty liver disease. World Journal of Gastroenterology 21:39, pages 11053.
Crossref
Elizabeth Housman & Rachel V. Reynolds. (2014) Polycystic ovary syndrome: A review for dermatologists. Journal of the American Academy of Dermatology 71:5, pages 847.e1-847.e10.
Crossref
Carly E Kelley. (2014) Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. World Journal of Gastroenterology 20:39, pages 14172.
Crossref
Justyna Kuliczkowska Plaksej, Lukasz Laczmanski, Andrzej Milewicz, A. Lenarcik-Kabza, Anna Trzmiel-Bira, Urszula Zaleska-Dorobisz, Felicja Lwow & Lidia Hirnle. (2014) Cannabinoid Receptor 1 Gene Polymorphisms and Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome and in Healthy Controls. International Journal of Endocrinology 2014, pages 1-8.
Crossref
Ancha Baranova, Thuy Phuong Tran, Arian Afendy, Lei Wang, Amirhossein Shamsaddini, Rohini Mehta, Vikas Chandhoke, Aybike Birerdinc & Zobair M Younossi. (2013) Molecular signature of adipose tissue in patients with both Non-Alcoholic Fatty Liver Disease (NAFLD) and Polycystic Ovarian Syndrome (PCOS). Journal of Translational Medicine 11:1.
Crossref
Susan R. Reutman & Juliana W. Meadows. 2013. Effects of Persistent and Bioactive Organic Pollutants on Human Health. Effects of Persistent and Bioactive Organic Pollutants on Human Health 237 314 .
Shivakumar Chitturi & Geoffrey C. Farrell. 2013. Non‐Alcoholic Fatty Liver Disease. Non‐Alcoholic Fatty Liver Disease 84 92 .
Ana C. TUYAMA & Charissa Y. CHANG. (2012) Non-alcoholic fatty liver disease. Journal of Diabetes 4:3, pages 266-280.
Crossref
Alita Mishra & Zobair M Younossi. (2012) Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease. Journal of Clinical and Experimental Hepatology 2:2, pages 135-144.
Crossref
L. F. N. Zueff, W. P. Martins, C. S. Vieira & R. A. Ferriani. (2012) Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome. Ultrasound in Obstetrics & Gynecology 39:3, pages 341-347.
Crossref
G. Vernon, A. Baranova & Z. M. Younossi. (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Alimentary Pharmacology & Therapeutics 34:3, pages 274-285.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.